Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids. Photo Credit: Carmen Yahchouchi/MSF
Press release
Press release |
07 July 2026
Diabetes

MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package

4 min
Ministry of Health laboratory technician Allieu Tucker conducts a subculture test on patients’ samples in the laboratory of the MSF-supported Government Maternity and Children’s Hospital in Hangha, Kenema District, Sierra Leone.
Press release
Press release |
16 June 2026
Research and development
Europe

Public investment demands public benefits: European Biotech Act must deliver for people

2 min
Salah Aldeen - nurse – places an intravenous line to Marwa, 3 years. Marwa was admitted the day before, as she was presenting common symptoms of measles. Amir, her big brother, who lies in the next tent, was admitted 5 days earlier for the same reason. Photo Credit: Thibault Fendler/MSF
Press release
Press release |
18 May 2026
Vaccines

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

5 min
"Osama", Patients in Nasser in urgent need of medical evacuation
Press release
Press release |
15 May 2026
Pandemic preparedness

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

2 min
MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA
Press release
Press release |
30 March 2026
HIV/AIDS

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab. Photo Credit: Gul Nayab
Press release
Press release |
24 March 2026
Tuberculosis

MSF demands sustained investments and political will to end neglect of children with tuberculosis

5 min
Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health. Photo credit: MSF/Martim Gray Pereira
Press release
Press release |
19 March 2026
Pandemic preparedness Research and development
European Union

MSF calls on EU to unlock progress in final Pandemic Agreement talks

2 min
"" Photo credit: Mudit Mathur
Press release
Press release |
05 March 2026
Intellectual property and trade
EuropeIndia

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury